If the filter system is FDA approved there could be a number of benefits. Lets assume that it doesn't clean out all of the nasty bugs and big pharma has to come in and add some of their snake oil...
Aethlon Medical, Inc. (OTCBB:AEMD Medical Stocks News) announced today that it has completed
the “first-in-man” study of a medical device to treat Human
Immunodeficiency Virus...
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing therapeutic
devices for infectious disease and advanced blood filtration, and
Delcath Systems, Inc....
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing therapeutic
devices for infectious disease, disclosed today that it has filed a
provisional patent submission...
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, disclosed today it has filed a provisional patent entitled, “Affinity Capture of Circulating...
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, announced today that researchers have documented the Aethlon Hemopurifier® is able...
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, announced today it has initiated a research collaboration to study the in vitro...
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing medical devices to treat infectious disease, disclosed today that its Chairman and CEO, James A. Joyce, will be presented the...
SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD), announced today that the U.S. Government has disclosed plans to support research, development, acquisition,...
SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) a pioneer in developing therapeutic devices for infectious disease, disclosed that its Chairman and CEO, James A. Joyce...
SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) disclosed this afternoon that its Chairman & CEO James A. Joyce will be interviewed live tomorrow on Market News...
SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, today announced it has entered into an $8.4 million...